Journal Article (Letter)

DKFZ-2019-01190

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial.

Weisel, K. C. ; Scheid, C. ; Zago, M. ; Besemer, B. ; Mai, E. K. ; Haenel, M. ; Duerig, J. ; Munder, M. ; Lindemann, H.-W. ; Seckinger, A. ; Kunz, C.DKFZ* ; Benner, A.DKFZ* ; Hose, D. ; Jauch, A. ; Salwender, H. ; Goldschmidt, H.

2019
Nature Publishing Group London [u.a.]

This record in other databases:  

Please use a persistent id in citations: doi:10.1038/s41408-019-0206-8

---

Contributing Institute(s):

1. Biostatistik (C060)

Research Program(s):

1. 313 - Cancer risk factors and prevention (POF3-313) (POF3-313)

Appears in the scientific report 2019

---

Database coverage:
; ; ; BIOSIS Previews ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DOAJ Seal ; IF >= 5 ; JCR ; NCBI Molecular Biology Database ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---